Translational Program in Cancer Research (CARE)
The CARE Program (Translational Program in Cancer Research) is a multidisciplinary network of researchers who share common interests and resources in the field of cancer research. The program is housed at the Can Ruti campus and is an integral part of the core scientific structure of the IGTP, an accredited center under Instituto de Salud Carlos III (ISCIII).
The IGTP presents CARE Translational Program in Cancer Research
Scope and aim
The program's research focuses on various forms of cancer, with the goal of accelerating the transfer of cutting-edge knowledge and technological progress in the diagnosis, treatment, and prevention of cancer. Through this program, the quality of cancer research will be enhanced and its impact in clinical practice will be maximised. The CARE Program has several scientific and functional aims that are designed to:
- Promote the development and implementation of precision and personalised medicine.
- Advance basic and translational research towards innovation and technology transfer.
- Establish a collaborative and transversal network of clinical, translational and basic researchers.
- Implement an efficient working framework among researchers to increase research impact.
- Enable advanced computational tools in translational research practices.
Structure of the program
Institutions:
- Core members: IGTP / HUGTiP / ICO.
- Associate institutions: IJC, IrsiCaixa, UAB.
Executive Committee:
- Directors: Mireia Margelí (Clinical research), Miguel A Peinado (Basic research).
- Sections' coordinators: Anna Martínez-Cardús (Networking), Eduard Serra (Scientific), Arola Fortian (Training & Communication).
2023 highlights
In 2023, the CARE Program made significant strides in enhancing cancer research and its application in clinical settings.
The program continued to organise seminars, courses and meetings, while also participating in outreach activities.
|
Nodes
As a new development, the program created focused nodes on translational cancer research:
- Preclinical models
- Immunology / Immunotherapy
- Tumour heterogeneity & liquid biopsy
Research groups
- B-ARGO (Badalona Applied Research Group in Oncology) (IGTP – CO)
- Molecular and Translational Pathology (IGTP – HUGTiP)
- Cancer Mechanisms and Pathways (IGTP)
- Cancer Genetics and Epigenetics (IGTP)
- Resistance, Chemotherapy and Predictive Biomarkers (IGTP -ICO)
- Endocrine Tumors (IGTP)
- Hereditary Cancer Group (IGTP)
- Translational Cancer Bioinformatics and Genomics (IGTP)
- Oncology Translational Research (OTR) (IGTP)
- Cancer Persister Cell Biology (IGTP)
- Childhood Liver Oncology (IGTP)
- Host-Immune Interactions (IrsiCaixa)
- Cancer Genetics (IJC)
- Cancer Heterogeneity and Hierarchies (IJC)